Effects of Secondhand Smoke on Flight Attendant Health (FAMRI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01639235|
Recruitment Status : Recruiting
First Posted : July 12, 2012
Last Update Posted : October 26, 2017
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||2000 participants|
|Official Title:||Cardiopulmonary Effects of Secondhand Smoke Exposure on Flight Attendants|
|Study Start Date :||January 2005|
|Estimated Primary Completion Date :||August 2018|
|Estimated Study Completion Date :||August 2018|
- Characterize the long-term effects of SHS on lung and cardiovascular function in pre-ban flight attendants [ Time Frame: 25 minutes ]A spirometry test is performed by the Clinical Research Coordinator to establish the lung function of the flight attendant participant and medical assistants from the cardiovascular care clinic administer a 12-lead non-invasive electrocardiogram.
- Clinical Examination [ Time Frame: 30 min ]The cardiologist performs a noninvasive assessment of the patient's vascular function, which includes a brief physical examination, blood pressure measurement, pulse, and oxygen level.
- Characterize the long term effects of prolonged flight time and SHS on reproductive health [ Time Frame: 10 minutes ]Flight attendants fill out the electronic Exposure Questionnaire prior to their appointments. Part of the Questionnaire is a section on reproductive health. The answers to these survey questions in addition to information gathered and saved in APeX during the clinic visit are used for analysis on reproductive health of flight attendants.
- Characterize the biomarkers of SHS exposure [ Time Frame: 10 minutes ]A 45 mL blood specimen is drawn from interested patients to be stored in the research lab as well as analyzed in a UCSF laboratory. Results of the blood analysis performed in the research labs, such as secondhand smoke biomarkers and advanced lipid biomarkers, will not be shared with the subject.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01639235
|Contact: Riya Jacobfirstname.lastname@example.org|
|Contact: Paula Tarr||415-502-2345||Paula.Tarr@ucsf.edu|
|United States, California|
|University of California, San Francisco (UCSF)||Recruiting|
|San Francisco, California, United States, 94143|
|Contact: Paula Tarr 415-502-2345 Paula.Tarr@ucsf.edu|
|Principal Investigator: Rita Redberg, MD|
|Sub-Investigator: Eveline Stock, MD|
|Principal Investigator:||Rita Redberg, MD||University of California, San Francisco|